Literature DB >> 21810817

Fenestrated endovascular repair of type IV thoracoabdominal aneurysms: device design and implantation technique.

Noel O'Brien1, Jonathan Sobocinski, Piervito d'Elia, Matthieu Guillou, Fillipo Maioli, Richard Azzaoui, Stéphan Haulon.   

Abstract

Treatment of thoracoabdominal aortic aneurysms has traditionally been by means of open surgery, but in recent years endovascular approaches have emerged as a viable and perhaps superior alternative. Some confusion appears to exist in discussions in the literature regarding the exact definition of the various types of thoracoabdominal aneurysm depending on whether open or endovascular repair is undertaken, with some authors comparing the preoperative extent of disease and others comparing the degree of aortic coverage required. Accurate preoperative planning and meticulous implantation technique are critical to successful outcomes with the endovascular approach. This study discusses the anatomical classification of type IV thoracoabdominal aneurysms as applied in open and endovascular surgery and outlines the authors' approach to the critical preoperative planning of endografts used to treat these aneurysms. The authors describe their techniques used to implant these devices, whether they consist of fenestrated or branched components, and some of the mechanisms by which minimization of complications such as spinal cord ischemia is sought.

Entities:  

Mesh:

Year:  2011        PMID: 21810817     DOI: 10.1177/1531003511408340

Source DB:  PubMed          Journal:  Perspect Vasc Surg Endovasc Ther        ISSN: 1521-5768


  2 in total

1.  Best surgical option for thoracoabdominal aneurysm repair - the endovascular approach.

Authors:  Marcelo Ferreira; Luiz Lanziotti; Rodrigo Cunha; Guilherme d'Utra
Journal:  Ann Cardiothorac Surg       Date:  2012-09

2.  Urine neutrophil gelatinase-associated lipocalin predicts outcome and renal failure in open and endovascular thoracic abdominal aortic aneurysm surgery.

Authors:  A Gombert; I Prior; L Martin; J Grommes; M E Barbati; A C Foldenauer; G Schälte; G Marx; T Schürholz; A Greiner; M J Jacobs; J Kalder
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.